Literature DB >> 20236743

Longitudinal evaluation of restricted mouth opening (trismus) in patients following primary surgery for oral and oropharyngeal squamous cell carcinoma.

B Scott1, J D'Souza, N Perinparajah, D Lowe, S N Rogers.   

Abstract

Trismus is a serious problem for some patients after oral and oropharyngeal cancer, and it has a detrimental impact on quality of life and function. We know of few published papers that include preoperative assessment in reports on the longitudinal outcomes of mouth opening after oral and oropharyngeal surgery. We prospectively measured mouth opening in patients who had primary surgery for oral and oropharyngeal cancer from baseline to six months to find out the characteristics at baseline and at discharge of those who develop trismus at six months. Ninety-eight patients were eligible between February 2007 and March 2008, and 64 (65%) were recruited into the study. The range of mouth opening was measured on three occasions: before operation, on the ward before discharge from hospital, and at follow-up six months after operation. Using a criterion of 35 mm or less as an indication of trismus, 30% (19/63) had trismus before operation, 65% (37/57) at hospital discharge, and 54% (26/48) at six month follow-up. Patients at high risk of trismus were those with T stage 3 or 4 cancers who required free flap reconstruction and adjuvant radiotherapy; radiotherapy was the most significant factor at six months. Trismus at discharge was a prediction of trismus at six months. Interventions such as spatulas or a passive jaw mobiliser should be targeted at patients at high risk early in the postoperative phase. The efficacy of such interventions needs further research.
Copyright © 2010 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20236743     DOI: 10.1016/j.bjoms.2010.02.008

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  14 in total

Review 1.  Etiopathogenesis of Trismus in Patients With Head and Neck Cancer: An Exploratory Literature Review.

Authors:  Radhu Raj; Krishnakumar Thankappan; Chandrasekhar Janakiram; Subramania Iyer; Anil Mathew
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-04-27

2.  Trismus in oral cancer patients undergoing surgery and radiotherapy.

Authors:  Padmanidhi Agarwal; H R Shiva Kumar; Kirthi Kumar Rai
Journal:  J Oral Biol Craniofac Res       Date:  2016-10-22

3.  TheraBite exercises to treat trismus secondary to head and neck cancer.

Authors:  Jolanda I Kamstra; Jan L N Roodenburg; Carien H G Beurskens; Harry Reintsema; Pieter U Dijkstra
Journal:  Support Care Cancer       Date:  2012-10-04       Impact factor: 3.603

4.  Oral symptoms and functional outcome related to oral and oropharyngeal cancer.

Authors:  Jolanda I Kamstra; Harriet Jager-Wittenaar; Pieter U Dijkstra; Paulien M Huisman; Rob P van Oort; Bernard F A M van der Laan; Jan L N Roodenburg
Journal:  Support Care Cancer       Date:  2010-08-13       Impact factor: 3.603

5.  Oral cancer malnutrition impacts weight and quality of life.

Authors:  Nils-Claudius Gellrich; Jörg Handschel; Henrik Holtmann; Gertrud Krüskemper
Journal:  Nutrients       Date:  2015-03-27       Impact factor: 5.717

Review 6.  Trismus following different treatment modalities for head and neck cancer: a systematic review of subjective measures.

Authors:  Sook Y Loh; Robert W J Mcleod; Hassan A Elhassan
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-25       Impact factor: 2.503

7.  Randomised feasibility study to compare the use of Therabite® with wooden spatulas to relieve and prevent trismus in patients with cancer of the head and neck.

Authors:  R Lee; S T Yeo; S N Rogers; A L Caress; A Molassiotis; D Ryder; P Sanghera; C Lunt; B Scott; P Keeley; R T Edwards; N Slevin
Journal:  Br J Oral Maxillofac Surg       Date:  2018-03-09       Impact factor: 1.651

8.  A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy.

Authors:  Lauren A Zatarain; Derek K Smith; Jie Deng; Jill Gilbert; Mary S Dietrich; Kenneth J Niermann; Sheila H Ridner; Barbara A Murphy
Journal:  Integr Cancer Ther       Date:  2018-06-28       Impact factor: 3.279

9.  Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.

Authors:  Sarah J van der Geer; Phillip V van Rijn; Jolanda I Kamstra; Johannes A Langendijk; Bernard F A M van der Laan; Jan L N Roodenburg; Pieter U Dijkstra
Journal:  Head Neck       Date:  2018-12-18       Impact factor: 3.147

10.  Variations in odontological care routines for patients undergoing treatment for head and neck cancer in county councils/regions of Sweden.

Authors:  Niklas Bohm; Charlott Karlsson; Jessica Skoogh Andersson; Annica Almståhl
Journal:  Clin Exp Dent Res       Date:  2019-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.